- Home
- BIVI vs MIRA Comparison
BIVI vs MIRA Comparison
Compare BIVI & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- MIRA
- Stock Information
- Founded
- BIVI 2013
- MIRA 2020
- Country
- BIVI United States
- MIRA United States
- Employees
- BIVI N/A
- MIRA N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- BIVI Health Care
- MIRA Health Care
- Exchange
- BIVI Nasdaq
- MIRA Nasdaq
- Market Cap
- BIVI 18.6M
- MIRA 19.5M
- IPO Year
- BIVI N/A
- MIRA 2023
- Fundamental
- Price
- BIVI $1.08
- MIRA $1.40
- Analyst Decision
- BIVI Strong Buy
- MIRA Strong Buy
- Analyst Count
- BIVI 1
- MIRA 2
- Target Price
- BIVI $30.00
- MIRA $14.00
- AVG Volume (30 Days)
- BIVI 282.1K
- MIRA 265.8K
- Earning Date
- BIVI 05-12-2025
- MIRA 05-14-2025
- Dividend Yield
- BIVI N/A
- MIRA N/A
- EPS Growth
- BIVI N/A
- MIRA N/A
- EPS
- BIVI N/A
- MIRA N/A
- Revenue
- BIVI N/A
- MIRA N/A
- Revenue This Year
- BIVI N/A
- MIRA N/A
- Revenue Next Year
- BIVI N/A
- MIRA N/A
- P/E Ratio
- BIVI N/A
- MIRA N/A
- Revenue Growth
- BIVI N/A
- MIRA N/A
- 52 Week Low
- BIVI $0.62
- MIRA $0.51
- 52 Week High
- BIVI $7.50
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- BIVI 53.42
- MIRA 62.38
- Support Level
- BIVI $1.07
- MIRA $1.29
- Resistance Level
- BIVI $1.13
- MIRA $1.44
- Average True Range (ATR)
- BIVI 0.06
- MIRA 0.10
- MACD
- BIVI 0.00
- MIRA 0.00
- Stochastic Oscillator
- BIVI 65.99
- MIRA 85.81
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.